Skip to main content

HCA Healthcare, Inc. income statement

  • HCA · NYSE
  • Healthcare
  • Health Care Facilities
  • S&P 500
$499.05−0.32%Close 13 Nov 2026 · Market value $107.0B

HCA Healthcare, Inc. reported revenue of $75.6 billion for fiscal year 2025 (the twelve months to 31 Dec 2025), up 7.1% from fiscal 2024. Net income was $6.78 billion and diluted earnings per share $28.33.

From HCA Healthcare, Inc.'s annual and quarterly reports, each period checked against accounting identities; a figure that does not pass is left blank. Fiscal years follow the company's calendar, the latest ending 31 Dec 2025. TTM is the last four reported quarters added up.

Annual

HCA Healthcare, Inc. income statement, annual
USDFY 2009FY 2010FY 2011FY 2012FY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025TTM
Revenue————$34.18B$36.92B$39.68B$41.49B$43.61B$46.68B$51.34B$51.53B$58.75B$60.23B$64.97B$70.60B$75.60B$78.70B
Revenue growth—————+8.0%+7.5%+4.6%+5.1%+7.0%+10.0%+0.4%+14.0%+2.5%+7.9%+8.7%+7.1%—
Net interest income————−$1.85B−$1.74B−$1.67B−$1.71B−$1.69B−$1.75B−$1.82B———————
Selling, general and administrative$164.0M$182.0M$228.0M$248.0M$287.0M$285.0M$327.0M$343.0M$340.0M$344.0M$370.0M$416.0M$337.0M$307.0M$353.0M$421.0M$548.0M$580.0M
Operating income$3.99B$4.33B$5.60B$4.69B$4.79B$5.22B$5.62B$6.52B$6.07B$7.07B$7.24B$7.25B$11.30B$10.35B$9.62B$10.56B$12.00B$12.12B
Operating margin————14.0%14.2%14.2%15.7%13.9%15.1%14.1%14.1%19.2%17.2%14.8%15.0%15.9%15.4%
Interest expense$1.99B$2.10B$2.04B$1.80B$1.85B$1.74B$1.67B$1.71B$1.69B$1.75B$1.82B$1.58B$1.57B$1.74B$1.94B$2.06B$2.25B$2.36B
Income before tax$2.00B$2.23B$3.56B$2.89B$2.95B$3.48B$3.96B$4.81B$4.38B$5.33B$5.24B$5.43B$9.83B$8.58B$7.71B$8.52B$9.83B$9.82B
Income tax expense$627.0M$658.0M$719.0M$888.0M$950.0M$1.11B$1.26B$1.38B$1.64B$946.0M$1.10B$1.04B$2.11B$1.75B$1.61B$1.87B$2.05B$2.02B
Effective tax rate31.3%29.5%20.2%30.7%32.2%31.8%31.9%28.6%37.4%17.7%21.0%19.2%21.5%20.3%21.0%21.9%20.9%20.6%
Net income$1.05B$1.21B$2.46B$1.60B$1.56B$1.88B$2.13B$2.89B$2.22B$3.79B$3.50B$3.75B$6.96B$5.64B$5.24B$5.76B$6.78B$6.78B
Net margin————4.6%5.1%5.4%7.0%5.1%8.1%6.8%7.3%11.8%9.4%8.1%8.2%9.0%8.6%
EPS · diluted$2.44$2.76$4.97$3.49$3.37$4.16$4.99$7.30$5.95$10.66$10.07$10.93$21.16$19.15$18.97$22.00$28.33$30.20
Diluted weighted average shares432M437M496M459M462M450M427M396M372M355M348M344M329M295M276M262M239M224M
Basic weighted average shares426M426M477M440M445M436M414M384M362M347M341M338M323M290M272M259M236M221M
EBITDA$5.41B$5.75B$7.06B$6.37B$6.55B$7.04B$7.53B$8.48B$8.20B$9.35B$9.83B$9.98B$14.15B$13.32B$12.70B$13.87B$15.53B$15.85B
EBITDA margin————19.2%19.1%19.0%20.4%18.8%20.0%19.2%19.4%24.1%22.1%19.5%19.6%20.5%20.1%
Depreciation & amortization$1.43B$1.42B$1.47B$1.68B$1.75B$1.82B$1.90B$1.97B$2.13B$2.28B$2.60B$2.72B$2.85B$2.97B$3.08B$3.31B$3.52B$3.74B
Stock-based compensation$40.00M$32.00M$26.00M$56.00M$113.0M$163.0M$239.0M$251.0M$270.0M$268.0M$347.0M$362.0M$440.0M$341.0M$262.0M$360.0M$401.0M$404.0M
Dividends per share—$9.43—$6.50—————$1.40$1.60$1.72$1.92$2.24$2.40$2.64$2.88$3.06

Quarterly

HCA Healthcare, Inc. income statement, quarterly
USDQ4 FY2023Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026
Revenue$17.30B$17.34B$17.49B$17.49B$18.29B$18.32B$18.61B$19.16B$19.51B$19.11B$20.23B$19.85B
Selling, general and administrative$62.00M$90.00M$100.0M$111.0M$120.0M$126.0M$130.0M$139.0M$153.0M$133.0M$148.0M$146.0M
Operating income$2.81B$2.76B$2.74B$2.41B$2.65B$2.86B$2.96B$2.96B$3.22B$2.86B$3.08B$2.96B
Operating margin16.2%15.9%15.7%13.8%14.5%15.6%15.9%15.5%16.5%15.0%15.2%14.9%
Interest expense$491.0M$512.0M$506.0M$515.0M$528.0M$547.0M$568.0M$561.0M$572.0M$584.0M$599.0M$607.0M
Income before tax$2.35B$2.25B$2.24B$1.91B$2.13B$2.33B$2.42B$2.42B$2.67B$2.29B$2.49B$2.37B
Income tax expense$484.0M$445.0M$550.0M$424.0M$447.0M$502.0M$524.0M$515.0M$509.0M$430.0M$564.0M$521.0M
Effective tax rate20.6%19.8%24.6%22.2%21.0%21.6%21.7%21.3%19.0%18.8%22.6%22.0%
Net income$1.61B$1.59B$1.46B$1.27B$1.44B$1.61B$1.65B$1.64B$1.88B$1.62B$1.70B$1.58B
Net margin9.3%9.2%8.4%7.3%7.9%8.8%8.9%8.6%9.6%8.5%8.4%8.0%
EPS · diluted$5.93$5.93$5.53$4.88$5.63$6.45$6.83$6.96$8.14$7.15$7.62$7.27
Diluted weighted average shares271M268M264M260M255M249M242M236M231M227M223M217M
Basic weighted average shares267M264M261M257M252M247M239M233M227M224M221M215M
EBITDA$3.60B$3.56B$3.56B$3.25B$3.51B$3.72B$3.83B$3.85B$4.13B$3.79B$4.02B$3.91B
EBITDA margin20.8%20.5%20.4%18.6%19.2%20.3%20.6%20.1%21.2%19.8%19.9%19.7%
Depreciation & amortization$789.0M$795.0M$819.0M$842.0M$856.0M$860.0M$863.0M$889.0M$911.0M$930.0M$944.0M$954.0M
Stock-based compensation$57.00M$87.00M$112.0M$76.00M$85.00M$98.00M$99.00M$104.0M$100.0M$86.00M$85.00M$133.0M
Dividends per share$0.60$0.66$0.66$0.66$0.66$0.72$0.72$0.72$0.72$0.78$0.78$0.78

The main figures as JSON and plain text. See data and methodology.

HCA in the terminal

Every line back twenty years, charts of any figure, segments and KPIs by quarter, valuation and alerts.